Swiss Life Sciences Stock News

SWX:SQN
SWX:SQNCapital Markets

Swissquote Group Holding (SWX:SQN) Margin Strength Reinforces Bullish Narratives In FY 2025 Results

Swissquote Group Holding (SWX:SQN) has put up a busy FY 2025 scorecard, with second half revenue of CHF 388.1 million and basic EPS of CHF 13.88 sitting alongside trailing twelve month revenue of CHF 760.8 million and EPS of CHF 24.49, underpinned by reported earnings growth of 24.6% over the last year. The company has seen revenue move from CHF 356.9 million in the second half of 2024 to CHF 372.7 million in the first half of 2025 and CHF 388.1 million in the second half of 2025, while net...
SWX:DOCM
SWX:DOCMConsumer Retailing

DocMorris (SWX:DOCM) EPS Loss Of CHF 2.11 Tests Bullish Revenue Growth Narratives

DocMorris (SWX:DOCM) has released fresh numbers for FY 2025, with first half revenue of CHF 541.5 million and a basic EPS loss of CHF 2.11 setting the tone, while over the trailing twelve months revenue reached CHF 1.1 billion against a basic EPS loss of CHF 3.47. Over recent periods, revenue has moved from CHF 496.3 million in H1 2024 to CHF 520.8 million in H2 2024 and CHF 541.5 million in H1 2025, as EPS has remained negative across all these halves. For investors, this mix of higher sales...
SWX:UHR
SWX:UHRLuxury

Swatch Group (SWX:UHR) Margin Collapse To 0.05% Tests Bullish Earnings Growth Narrative

Swatch Group (SWX:UHR) has delivered a soft set of FY 2025 numbers, with second half revenue of CHF 3.2b and net income excluding extra items of essentially break even, alongside a current share price of CHF 164.45. The company has seen half year revenue move from CHF 3.3b in second half 2024 to CHF 3.1b in first half 2025 and CHF 3.2b in second half 2025. Net income excluding extra items shifted from CHF 57m to CHF 3m and then to zero over the same periods, setting up a story where wafer...
SWX:LOGN
SWX:LOGNTech

Logitech Leadership Shift And Buyback Plan Meet Mixed Share Performance

Logitech International (SWX:LOGN) has appointed Yalcin Yilmaz as its new Chief Commercial Officer, marking a key shift in its leadership team. The board has approved a new three year share buyback program, signaling a clear capital return plan for shareholders. The company has expanded its Racing Series Ecosystem with the launch of the RS H Shifter, adding a fresh product to its simulation portfolio. Logitech International, trading at CHF71.12, sits at an interesting point for investors...
SWX:SCMN
SWX:SCMNTelecom

Assessing Swisscom (SWX:SCMN) Valuation After New Telecom Italia Mobile Towers Expansion Plan

Swisscom (SWX:SCMN) is in the spotlight after announcing a collaboration with Telecom Italia to develop up to 6,000 mobile tower sites across Italy, a move that extends its existing international infrastructure footprint. See our latest analysis for Swisscom. At a share price of CHF704.5, Swisscom has seen modest short term softness, with a 1 day share price return of a 1.1% decline and a 7 day share price return of a 0.8% decline. However, the 90 day share price return of 23.7% and 1 year...
SWX:ROG
SWX:ROGPharmaceuticals

Roche Expands Mass Spec Reach And Builds India Research Ties

Roche Holding's Ionify steroid assays for mass spectrometry have received U.S. FDA moderate complexity classification, widening access to advanced steroid hormone testing in clinical labs. Roche Pharma India has signed an MoU with NIPER Raebareli to collaborate on pharmaceutical education and research. These developments relate to both Roche's diagnostics portfolio and its global R&D footprint, including activity in India. Roche Holding (SWX:ROG) is drawing attention with regulatory...
SWX:NOVN
SWX:NOVNPharmaceuticals

Novartis Adds Rare Disease Depth And Cardiovascular Optionality For Investors

Novartis received FDA approval for Cosentyx to treat pediatric hidradenitis suppurativa, expanding options for adolescent patients with this chronic skin disease. The approval makes Cosentyx the first IL-17A inhibitor cleared for this pediatric indication in the United States. Novartis also signed a licensing agreement with Unnatural Products to develop macrocyclic peptide therapeutics for cardiovascular diseases. The deal targets previously hard-to-address cardiovascular drug targets and...
SWX:UBSG
SWX:UBSGCapital Markets

UBS Outage Tests Tech Resilience And Credit Suisse Integration Story

UBS Group (SWX:UBSG) experienced a global technology outage that briefly halted parts of its trading operations. The disruption affected certain trading systems across regions before services were restored. The outage comes while UBS is integrating Credit Suisse's data and infrastructure following the recent acquisition. The incident adds to a series of similar technology disruptions reported at other large financial institutions. For you as an investor, this outage sits at the intersection...
SWX:EPIC
SWX:EPICReal Estate

EPIC Suisse (SWX:EPIC) Valuation Check After 2026 Guidance And Higher Dividend Proposal

EPIC Suisse (SWX:EPIC) issued 2026 guidance pointing to 2% to 3% net rental income growth, supported by completed developments PULSE and Campus Leman, and proposed lifting its dividend to CHF 3.20 per share. See our latest analysis for EPIC Suisse. The latest guidance and dividend proposal come after a period of steadier momentum, with a 90 day share price return of 8.39% and a 1 year total shareholder return of 20.90%, highlighting how sentiment has improved over a longer horizon. If this...
SWX:SMG
SWX:SMGInteractive Media and Services

SMG Swiss Marketplace Group Holding (SWX:SMG) EPS Jump Tests Bullish Growth Narratives

SMG Swiss Marketplace Group Holding (SWX:SMG) has put fresh numbers on the table for FY 2025, with first half revenue of CHF 175.8 million and basic EPS of CHF 11.48, providing a clear reference point against last year’s CHF 152.2 million in revenue and CHF 8.99 EPS for the same period. The company has seen revenue move from CHF 152.2 million to CHF 175.8 million and EPS shift from CHF 8.99 to CHF 11.48 year on year for the first half. Trailing 12 month figures show EPS ranging between CHF...
SWX:MED
SWX:MEDMedical Equipment

Medartis Holding (SWX:MED) Half Year Loss Challenges High Growth Profitability Narrative

Medartis Holding (SWX:MED) opened FY 2025 with first half revenue of CHF123.0 million and a basic EPS loss of CHF0.12, while trailing twelve month figures show revenue of CHF269.3 million and basic EPS of CHF0.67. Over the last few reported periods, revenue has moved from CHF111.5 million in H1 2024 to CHF113.3 million in H2 2024 and then to CHF123.0 million in H1 2025. Basic EPS shifted from CHF0.21 in H1 2024 to CHF0.09 in H2 2024 before dipping into a loss of CHF0.12 in H1 2025, putting...
SWX:TXGN
SWX:TXGNMedia

TX Group (SWX:TXGN) Swings To CHF 8.3 Million Loss Challenging Profitability Recovery Narratives

TX Group (SWX:TXGN) has opened FY 2025 with first half revenue of CHF 426.6 million and EPS of CHF 0.8 loss, while the trailing twelve month figures show revenue of CHF 873.1 million and net income of CHF 36.6 million. Over recent reporting periods, revenue has ranged between CHF 461 million and CHF 480.7 million, with EPS moving from a CHF 0.9 profit to losses of CHF 1.22 and CHF 2.02. This highlights a business where headline growth expectations and actual profitability appear to be pulling...
SWX:NESN
SWX:NESNFood

A Look At Nestlé (SWX:NESN) Valuation As It Expands Frozen Meals Pizzas And Functional Coffee

Nestlé (SWX:NESN) is pushing harder into U.S. frozen meals and pizzas, while expanding flavored and functional coffee lines. These moves are aimed at attracting health focused and younger consumers across two of its key categories. See our latest analysis for Nestlé. Nestlé's latest push into frozen meals, pizzas and specialty coffee comes after a softer share price patch, with a 30 day share price return of 2.74% and a 1 year total shareholder return decline of 10.02% that contrasts with...
SWX:ABBN
SWX:ABBNElectrical

ABB And NVIDIA Tie RobotStudio HyperReality To Long Term Robotics Story

ABB Robotics (SWX:ABBN) launched its next generation AI powered RobotStudio HyperReality platform with NVIDIA, integrating Omniverse libraries for virtual to real robot deployment. The platform lets customers design, simulate, train, and optimize robots in a virtual environment with close alignment to real world performance. Early pilots with Foxconn and a demonstration with WORK show the concept applied to both large manufacturers and smaller enterprises. ABB, through its Robotics...
SWX:SDZ
SWX:SDZPharmaceuticals

A Look At Sandoz Group’s (SWX:SDZ) Valuation After Debt Refinancing And Biosimilars Reorganization

Sandoz Group (SWX:SDZ) has drawn investor attention after issuing CHF 550 million in dual tranche bonds and extending a US$2,000 million revolving credit facility, while reshaping its biosimilar organization under new leadership. See our latest analysis for Sandoz Group. These financing moves and the reshaping of the biosimilar unit come as Sandoz trades at CHF62.9, with a 90 day share price return of 9.51% and a 1 year total shareholder return of 69.39%. This indicates momentum building over...
SWX:LISN
SWX:LISNFood

Assessing Lindt & Sprüngli (SWX:LISN) Valuation After Strong 2025 Earnings And Dividend Announcement

Chocoladefabriken Lindt & Sprüngli (SWX:LISN) has drawn fresh attention after releasing full year 2025 results, showing higher sales, revenue and net income, and announcing an annual dividend of CHF 1,800 per share. See our latest analysis for Chocoladefabriken Lindt & Sprüngli. At a share price of CHF 112,800, Chocoladefabriken Lindt & Sprüngli has seen a 7 day share price return of 0.71%, while the 30 day share price return of an 8.14% decline contrasts with a 5 year total shareholder...
SWX:SLHN
SWX:SLHNInsurance

What Swiss Life Holding (SWX:SLHN)'s 2025 Earnings Beat and Higher Dividend Means For Shareholders

On 12 March 2026, Swiss Life Holding AG reported full-year 2025 results showing net income of CHF 1,234 million and slightly higher earnings per share, while also announcing an annual dividend of CHF 36.50 per share payable on 13 May 2026. The combination of steady profit growth and a higher cash distribution offers fresh insight into how Swiss Life balances shareholder returns with capital needs. With Swiss Life pairing higher earnings per share and an increased CHF 36.50 dividend, we’ll...
SWX:BCGE
SWX:BCGEBanks

BCGE (SWX:BCGE) Margin Compression Challenges Bullish Profitability Narratives

Banque Cantonale de Genève (SWX:BCGE) has put out fresh FY 2025 numbers, with first half revenue at CHF263.3 million and net income at CHF94.0 million setting the tone for how the year is shaping up. Over recent periods the bank has seen revenue move from CHF287.9 million in 1H 2024 to CHF273.8 million in 2H 2024 and then CHF263.3 million in 1H 2025, while trailing twelve month net income excluding extra items sits at CHF197.2 million against a backdrop of a 36.7% net profit margin that is...
SWX:STGN
SWX:STGNMachinery

StarragTornos Group (SWX:STGN) Swings To CHF9.1m H1 Loss Challenging Profitability Narratives

StarragTornos Group (SWX:STGN) has just posted its FY 2025 first half results, with revenue of CHF218.2 million and a basic EPS loss of CHF1.66, while trailing twelve month figures show revenue of CHF457.3 million and a basic EPS loss of CHF0.69. Over recent reporting periods, revenue has moved from CHF254.9 million and EPS of CHF1.20 in 2024 H1 to CHF239.1 million and EPS of CHF0.97 in 2024 H2, before reaching the latest half-year levels. For investors, the focus is on how these changing...
SWX:BAER
SWX:BAERCapital Markets

Julius Bär Gruppe (SWX:BAER) Net Margin Drop Challenges Bullish Earnings Narrative

Julius Bär Gruppe (SWX:BAER) has posted its FY 2025 results with second half revenue of CHF 1,950.2 million and basic EPS of CHF 2.28, while trailing twelve month revenue came in at CHF 3,760.4 million and EPS at CHF 3.72. Over recent periods the bank has seen revenue move from CHF 1,916.3 million in the second half of 2024 to CHF 1,810.2 million in the first half of 2025 and then to CHF 1,950.2 million in the latest half, alongside EPS shifting from CHF 2.78 to CHF 1.44 and then CHF 2.28...
SWX:UBXN
SWX:UBXNSemiconductor

Assessing u-blox (SWX:UBXN) Valuation After New GNSS Platform And Module Launches

u-blox Holding (SWX:UBXN) has just rolled out two GNSS products: the u-blox F11 platform and the ZED-X20D module, spotlighting its focus on low power positioning and precise heading across tracking, wearable, and industrial applications. See our latest analysis for u-blox Holding. The product launches come after a strong run in the share price, with the stock trading at CHF135.0 and a 90 day share price return of 25.46%, while the 1 year total shareholder return stands at 108.01% and the 5...
SWX:ALC
SWX:ALCMedical Equipment

Is It Time To Reassess Alcon (SWX:ALC) After A 22% One Year Share Price Slide

If you are wondering whether Alcon's current share price reflects its true worth, this article walks through the key numbers that matter for you as an investor. Alcon recently closed at $61.16, with returns of a 2.5% decline over 7 days, 0.3% over 30 days, a 3.7% decline year to date and a 22.2% decline over the past year, which raises questions about how the market is currently pricing the stock. Recent coverage around Alcon has focused on its position in the medical equipment space and how...
SWX:HIAG
SWX:HIAGReal Estate

A Look At HIAG Immobilien Holding (SWX:HIAG) Valuation After Strong 2025 Results And Higher Proposed Dividend

HIAG Immobilien Holding (SWX:HIAG) is back in focus after reporting full year 2025 results, with revenue of CHF 218.1 million and net income of CHF 115.1 million, alongside a higher proposed dividend. See our latest analysis for HIAG Immobilien Holding. HIAG Immobilien Holding’s recent earnings and dividend proposals have come alongside a 16.31% 90 day share price return and a 44.25% 1 year total shareholder return, suggesting positive momentum following the results. If this earnings driven...
SWX:BANB
SWX:BANBLife Sciences

Bachem Holding (SWX:BANB) Margin Improvement Reinforces Bullish Profitability Narratives

Bachem Holding (SWX:BANB) has just wrapped up FY 2025 with second half revenue of CHF 382.1 million and basic EPS of CHF 1.31, alongside trailing twelve month revenue of CHF 695.1 million and EPS of CHF 1.98 that sit against a 23.7% earnings growth figure for the year. The company has seen revenue move from CHF 605.3 million to CHF 695.1 million on a trailing basis, while EPS has shifted from CHF 1.60 to CHF 1.98. This sets up a story of higher sales translating into improved earnings per...